By entering this website, you certify that you are at least 18 years of age and agree to the following conditions:
GLP-2-TZ is a synthetic peptide that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Unlike single-agonist peptides, GLP-2-TZ is engineered to integrate the metabolic signaling of both incretin hormones. In research settings, it is primarily studied for its superior efficacy in modulating glycemic control, insulin sensitivity, and adipose tissue metabolism compared to selective GLP-1 analogs.
